-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Northwest Biotherapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Northwest Biotherapeutics Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$14.8M, a 7.06% decline year-over-year.
- Northwest Biotherapeutics Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$63.2M, a 7.87% decline year-over-year.
- Northwest Biotherapeutics Inc annual Operating Income (Loss) for 2023 was -$55.5M, a 17.4% increase from 2022.
- Northwest Biotherapeutics Inc annual Operating Income (Loss) for 2022 was -$67.2M, a 27.5% decline from 2021.
- Northwest Biotherapeutics Inc annual Operating Income (Loss) for 2021 was -$52.7M, a 39.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)